Can existing drugs slow Covid-19?
The fastest route to treatments may be to repurpose existing drugs – if they work
Getting ideas across
In a diverse industry like chemicals, we need to make sure we’re open to learning from unexpected angles.
Data is lacking as Reach moves beyond registration
Enforcing the demanding rules of Europe’s chemical legislation is keeping regulators and companies on their toes
FDA freezes foreign facility inspections amid coronavirus pandemic
US regulator will rely on border checks and shared data, but some approval processes may be delayed
